Back to Search
Start Over
Supplementary Figure 5 from AZD0364 Is a Potent and Selective ERK1/2 Inhibitor That Enhances Antitumor Activity in KRAS-Mutant Tumor Models when Combined with the MEK Inhibitor, Selumetinib
- Publication Year :
- 2023
- Publisher :
- American Association for Cancer Research (AACR), 2023.
-
Abstract
- Supplementary Figure 5
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....3096ba14b346b57ffe19ec155108e122
- Full Text :
- https://doi.org/10.1158/1535-7163.22521550